Northwest Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Northwest Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,569	Closed	-$102K	–	375
2019 Q1	$102K	Sell	1,569 -6	-0.4%	-$394	0.08%	160
2018 Q4	$98K	Sell	1,575 -60	-4%	-$4.05K	0.08%	147
2018 Q3	$120K	Sell	1,635 -137	-8%	-$9.83K	0.09%	138
2018 Q2	$119K	Sell	1,772 -45	-2%	-$2.9K	0.09%	137
2018 Q1	$113K	Buy	+1,817	New	+$120K	0.08%	139

Other funds holding PJP

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Northwest Wealth Management's PJP Position: Q2 2019 in Review

Northwest Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2019, closing a stake of 1,569 shares — an estimated $102K sold.

Northwest Wealth Management first reported a position in PJP in Q1 2018 and held it in 5 quarters. The position peaked at $120K in Q3 2018. 83 funds tracked by Wall St. Rank hold PJP as of Q2 2019.

Northwest Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
Northwest Wealth Management sold 1,569 Invesco Pharmaceuticals ETF shares in Q2 2019, an estimated $102K.
Northwest Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2018 and held it in 5 quarters.
Northwest Wealth Management's Invesco Pharmaceuticals ETF position peaked at $120K in Q3 2018.
83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2019.

Based on Northwest Wealth Management's 13F filing for Q2 2019, filed 23 Jul 2019.